MICHAEL ROSENBLATT, M.D.
Osteopathic Medicine at Harrison Ave, Boston, MA
License number
Massachusetts 37320
Category
Osteopathic Medicine
Type
Endocrinology, Diabetes & Metabolism
Address
Address
2
136 Harrison Ave, Boston, MA 02111
130 Lake Ave, Newton, MA 02459
130 Lake Ave, Newton, MA 02459
Phone
(617) 636-6565
Personal information
See more information about MICHAEL ROSENBLATT at radaris.comName
Address
Phone
334 S Great Rd, Lincoln, MA 01773
41 Rosalie Rd, Needham Heights, MA 02494
331 Dudley Rd, Newton Center, MA 02459
2 Atwood St, Wellesley, MA 02482
164 Sunset Ave, Amherst, MA 01002
Organization information
See more information about MICHAEL ROSENBLATT at bizstanding.comMichael Rosenblatt
331 Dudley Rd, Newton, MA 02459
Categories:
Business Services
Phone:
(617) 928-9856 (Phone)
Professional information
See more information about MICHAEL ROSENBLATT at trustoria.com
Chief Medical Officer- Lahey Hospital And Medical Center- Burlington
Chief Medical Officer- Lahey Hospital And Medical Center- Burlington
Position:
Chief Medical Officer- Burlington Hospital at Lahey Clinic, Surgeon at Lahey Clinic
Location:
Greater Boston Area
Industry:
Hospital & Health Care
Work:
Lahey Clinic
- Burlington, MA since Jul 2011
-
Chief Medical Officer- Burlington Hospital
Lahey Clinic
since 1993
-
Surgeon
Baldrige National Quality Program, NIST
2001 - 2011
-
Alumni Examiner
Baldrige Performance Excellence Program
2001 - 2011
-
Alumni Examiner
Malcolm Baldrige National Quality Award
2007 - 2010
-
Judge
Education:
Boston University - School of Management 1993 - 1997
MBA Boston University School of Public Health 1987 - 1989
MPH Jefferson Medical College of Thomas Jefferson University 1980 - 1984
MD, Medicine Wesleyan University 1976 - 1980
BA, Biology-Psychology
MBA Boston University School of Public Health 1987 - 1989
MPH Jefferson Medical College of Thomas Jefferson University 1980 - 1984
MD, Medicine Wesleyan University 1976 - 1980
BA, Biology-Psychology
Dr. Michael Rosenblatt, Boston MA - MD (Doctor of Medicine)
Dr. Michael Rosenblatt, Boston MA - MD (Doctor of Medicine)
Specialties:
Endocrinology, Diabetes & Metabolism, Endocrinology & Metabolism
Address:
33 Avenue Louis Pasteur, Boston 02115
(617) 992-2041 (Phone)
(617) 992-2041 (Phone)
Certifications:
Diabetes, Metabolism & Endocrinology, 1977, Internal Medicine, 1976
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
33 Avenue Louis Pasteur, Boston 02115
Beth Israel Deaconess Medical Center
330 Brookline Ave, Boston 02215
Beth Israel Deaconess Medical Center
330 Brookline Ave, Boston 02215
Education:
Medical School
Harvard Medical School
Massachusetts General Hospital
Harvard Medical School
Massachusetts General Hospital
Virtual Representatives For Use As Communications Tools
Virtual Representatives For Use As Communications Tools
US Patent:
2002000, Jan 17, 2002
Filed:
May 1, 2001
Appl. No.:
09/847026
Inventors:
Michael Rosenblatt - Newton MA, US
Lucille Salhany - Dover MA, US
Richard Guttendorf - Elkton MD, US
Serge LaFontaine - Lincoln MA, US
Lucille Salhany - Dover MA, US
Richard Guttendorf - Elkton MD, US
Serge LaFontaine - Lincoln MA, US
International Classification:
G10L013/08
US Classification:
704/260000
Abstract:
A system and method for enabling the use of photo-realistic, three-dimensional virtual representatives in a variety of communications settings is disclosed. A first module is employed for selecting a virtual representative to be used for communicating with a user, for defining text to be voiced by the selected virtual representative, and for inserting emotion cues into that text. A second module responds to data from the first module by generating an image of the virtual representative, then controls changes in the image in accordance with the text to be voiced and the corresponding emotion cues. A third module is employed for defining virtual representatives and the response of virtual representatives to emotion cues associated with text to be voiced. The modularity of the presently disclosed invention lends itself to the integration into a variety of settings, including Web pages, email and PC games.
Analogs Of Parathyroid Hormone And Pth-Related Protein As Bone Anabolic Agents
Analogs Of Parathyroid Hormone And Pth-Related Protein As Bone Anabolic Agents
US Patent:
7799757, Sep 21, 2010
Filed:
Jun 13, 2003
Appl. No.:
10/516224
Inventors:
Michael Chorev - Chestnut Hill MA, US
Michael Rosenblatt - Newton Centre MA, US
Michael Rosenblatt - Newton Centre MA, US
International Classification:
A61K 38/00, A61K 38/16, A61K 38/29, C07K 14/00, C07K 14/575, C07K 14/635
US Classification:
514 12, 514 2, 530300, 530324, 530399
Abstract:
Novel parathyroid hormone analogs and parathyroid hormones-related protein analogs are described. Further, methods of using these analogs to treat osteoporosis, promote the formation of bone, and inhibit bone loss are described.
Pth2 Receptor Selective Compounds
Pth2 Receptor Selective Compounds
US Patent:
2009022, Sep 10, 2009
Filed:
Mar 27, 2009
Appl. No.:
12/413303
Inventors:
Zheng Xin Dong - Holliston MA, US
Michael Chorev - Chestnut Hill MA, US
Michael Rosenblatt - Newton Centre MA, US
Michael Chorev - Chestnut Hill MA, US
Michael Rosenblatt - Newton Centre MA, US
International Classification:
A61K 39/00, C07K 14/00, A61K 38/16
US Classification:
4241851, 530324, 514 12
Abstract:
This invention relates to a series of PTH and PTHrP analogues that selectively bind to PTH2 receptors and as such may be useful in treating abnormal CNS functions; abnormal pancreatic functions; divergence from normal mineral metabolism and homeostasis; male infertility; regulation of abnormal blood pressure; and hypothalmic disease.
Inhibitors Of Peptide Hormone Action
Inhibitors Of Peptide Hormone Action
US Patent:
4423037, Dec 27, 1983
Filed:
May 13, 1982
Appl. No.:
6/377839
Inventors:
Michael Rosenblatt - Newton Highlands MA
John T. Potts - West Newton MA
John T. Potts - West Newton MA
Assignee:
The General Hospital Corporation - Boston MA
International Classification:
A61K 3700, C07C10352
US Classification:
424177
Abstract:
The present invention relates to the use of peptide hormone analogues as inhibitors of their respective naturally occurring peptide hormone. The structure of the peptide hormone analogues is exemplified by parathyroid hormone wherein the three N-terminal amino acids are removed and zero or more of the next four N-terminal amino acids are removed sequentially from the N-terminus.
Continuous Low-Dose Administration Of Parathyroid Hormone Or Its Agonist
Continuous Low-Dose Administration Of Parathyroid Hormone Or Its Agonist
US Patent:
5747456, May 5, 1998
Filed:
Sep 30, 1996
Appl. No.:
8/724539
Inventors:
Michael Chorev - Brookline MA
Michael Rosenblatt - Newton Centre MA
Michael Rosenblatt - Newton Centre MA
Assignee:
Beth Israel Deaconess Medical Center - Boston MA
International Classification:
C07K 1400, A61K 5100, G01N 33534
US Classification:
514 12
Abstract:
A method of promoting bone formation in a human patient, which includes the step of administering continuously to the patient parathyroid hormone or its agonist for a period of at least one month at a dosage between 10 and 400 units/24 hrs. Also disclosed are novel parathyroid hormone agonists.
System And Method For Simplified Data Transfer
System And Method For Simplified Data Transfer
US Patent:
8458363, Jun 4, 2013
Filed:
Sep 30, 2008
Appl. No.:
12/286398
Inventors:
Michael Rosenblatt - Newton Centre MA, US
Gloria Lin - San Ramon CA, US
Amir Mahood Mikhak - Cambridge MA, US
Taido Lantz Nakajima - Cupertino CA, US
Sean Anthony Mayo - Dover NH, US
Andrew Hodge - Palo Alto CA, US
Anthony Michael Fadell - Portola Valley CA, US
Gloria Lin - San Ramon CA, US
Amir Mahood Mikhak - Cambridge MA, US
Taido Lantz Nakajima - Cupertino CA, US
Sean Anthony Mayo - Dover NH, US
Andrew Hodge - Palo Alto CA, US
Anthony Michael Fadell - Portola Valley CA, US
Assignee:
Apple Inc. - Cupertino CA
International Classification:
G06F 15/16
US Classification:
709248
Abstract:
Systems and methods of performing a simplified data transfer are provided. For example, a simplified data transfer system may include two or more devices configured to perform a simplified data transfer. The first device may be configured to save and transfer data associated with applications open on the first device. When the second device initiates communication, the first device may automatically send the open application data to the second device.
Pth2 Receptor Selective Compounds
Pth2 Receptor Selective Compounds
US Patent:
7531621, May 12, 2009
Filed:
May 3, 1999
Appl. No.:
09/674597
Inventors:
Zheng Xin Dong - Framingham MA, US
Michael Chorev - Chestnut Hill MA, US
Michael Rosenblatt - Newton Centre MA, US
Michael Chorev - Chestnut Hill MA, US
Michael Rosenblatt - Newton Centre MA, US
Assignee:
Societe de Conseils de Recherches et d'Applications Scientifiques S.A.S. - Paris
Beth Israel - Boston MA
Beth Israel - Boston MA
International Classification:
C07K 5/00, A61K 38/16, A61K 38/29, A61K 38/00
US Classification:
530300, 530324, 514 2, 514 12
Abstract:
This invention relates to a series of PTH and PTHrP analogues that selectively bind to PTH2 receptors and as such may be useful in treating abnormal CNS functions; abnormal pancreatic functions; divergence from normal mineral metabolism and homeostasis; male infertility; regulation of abnormal blood pressure; and hypothalmic disease.
Cyclic Analogs Of Pth And Pthrp
Cyclic Analogs Of Pth And Pthrp
US Patent:
5717062, Feb 10, 1998
Filed:
Jun 7, 1995
Appl. No.:
8/488105
Inventors:
Michael Chorev - Brookline MA
Michael Rosenblatt - Newton Center MA
Michael Rosenblatt - Newton Center MA
Assignee:
Beth Israel Hospital Association - Boston MA
International Classification:
A61K 3800, C07K 500, C07K 700, C07K 1600
US Classification:
530317
Abstract:
Cyclic analogs of PTH and PTHrP wherein a disulfide or amide bond links the side chains of residues A. sub. 13 and A. sub. 17, A. sub. 26 and A. sub. 30, or A. sub. 13 and A. sub. 17 and A. sub. 26 and A. sub. 30.